Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × dostarlimab × Clear all

Phase

Status

Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Endometrial Neoplasms 7 Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Colonic Neoplasms 4 Neoplasm Metastasis 3 Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1

Interventions

Gemcitabine 56 130-nm albumin-bound paclitaxel 28 Specimen Handling 18 Magnetic Resonance Spectroscopy 18 Taxes 17 Albumin-Bound Paclitaxel 17 Leucovorin 16 Fluorouracil 16 pembrolizumab 15 Oxaliplatin 15 Drug Therapy 14 Irinotecan 12 Cyclophosphamide 11 Biopsy 11 fludarabine 10 Blood Specimen Collection 10 olaparib 7 irinotecan sucrosofate 7 folfirinox 6 Cetuximab 6 Capecitabine 6 dehydroftorafur 5 Radiotherapy 5 Radiosurgery 5 Magnetic Resonance Imaging 5 Cisplatin 5 Bevacizumab 5 sintilimab 4 durvalumab 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06757244 2025-03-18

DOVIPA

Hopital Foch

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡